FDA Considers Faster Approval Process for Obesity Drugs

Obesity treatments, life-saving antibiotics and other drugs deemed to offer societal benefit despite their risks may get speedier U.S. approvals under plans being discussed to better balance innovation and safety.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.